Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir/Emtricitabine-Tenofovir versus Entecavir in chronic hepatitis B with decompensated liver disease or post-transplant recurrence prevention
2005-004096-37Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Chronic Hepatitis B (CHB) comparing Viread, Truvada and Baraclude (3 arms). Primary endpoints: Safety and tolerability and Preliminary relative efficacy. Started Feb 2006; status: completed.
02
Drugs
tenofovir disoproxil fumarateemtricitabine + tenofovir disoproxilentecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2005-004096-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004096-37.